Search research articles
Contact Us
Filters
Showing results (1-10 of 237) with videos related to
Page
of 24
Sort By:
Critical Reviews in Oncology/Hematology
|
October 16, 2024
Corrigendum to "The emerging HER2 landscape in Colorectal Cancer: The key to unveil the future treatment algorithm?" [Crit. Rev. Oncol./Hematol. 204 (2024) 104515]
Lorenzo Antonuzzo
European Urology
|
September 28, 2025
Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.002
Giandomenico Roviello, Lorenzo Antonuzzo
European Urology
|
May 1, 2026
Re: Perioperative enfortumab vedotin and pembrolizumab in bladder cancer
Giandomenico Roviello, Lorenzo Antonuzzo
European Urology
|
January 14, 2026
Re: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
Giandomenico Roviello, Silvia Mancini, Lorenzo Antonuzzo
Cancer Research
|
February 21, 2024
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Cancer
|
October 9, 2025
From treatment escalation to ultra de-intensification: When androgen-deprivation therapy alone remains a rational choice in metastatic hormone-sensitive prostate cancer
Giandomenico Roviello, Martina Catalano, Lorenzo Antonuzzo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Are circulating tumor cells a new, valid prognostic marker in neuroendocrine tumors?
Lorenzo Antonuzzo, Giulia Meoni, Francesco Di Costanzo
European Urology
|
January 13, 2026
Re: ctDNA-guided Adjuvant Atezolizumab in Muscle-invasive Bladder Cancer
Giandomenico Roviello, Ismaela Anna Vascotto, Lorenzo Antonuzzo
The Journal of Urology
|
July 7, 2023
Editorial Comment
Riccardo Campi, Alessio Pecoraro, Lorenzo Antonuzzo, et al.
Heliyon
|
May 2, 2024
Unconventional strategy could be the future: From target to KRAS broad range treatment
Sara Fancelli, Giulia Petroni, Serena Pillozzi, et al.
Page
of 24
Search research articles
Search
Showing results (1-10 of 237) with videos related to
Sort By:
Page
of 24
Critical Reviews in Oncology/Hematology
|
October 16, 2024
Corrigendum to "The emerging HER2 landscape in Colorectal Cancer: The key to unveil the future treatment algorithm?" [Crit. Rev. Oncol./Hematol. 204 (2024) 104515]
Lorenzo Antonuzzo
European Urology
|
September 28, 2025
Re: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, et al. Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.002
Giandomenico Roviello, Lorenzo Antonuzzo
European Urology
|
May 1, 2026
Re: Perioperative enfortumab vedotin and pembrolizumab in bladder cancer
Giandomenico Roviello, Lorenzo Antonuzzo
European Urology
|
January 14, 2026
Re: Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
Giandomenico Roviello, Silvia Mancini, Lorenzo Antonuzzo
Cancer Research
|
February 21, 2024
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Cancer
|
October 9, 2025
From treatment escalation to ultra de-intensification: When androgen-deprivation therapy alone remains a rational choice in metastatic hormone-sensitive prostate cancer
Giandomenico Roviello, Martina Catalano, Lorenzo Antonuzzo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2013
Are circulating tumor cells a new, valid prognostic marker in neuroendocrine tumors?
Lorenzo Antonuzzo, Giulia Meoni, Francesco Di Costanzo
European Urology
|
January 13, 2026
Re: ctDNA-guided Adjuvant Atezolizumab in Muscle-invasive Bladder Cancer
Giandomenico Roviello, Ismaela Anna Vascotto, Lorenzo Antonuzzo
The Journal of Urology
|
July 7, 2023
Editorial Comment
Riccardo Campi, Alessio Pecoraro, Lorenzo Antonuzzo, et al.
Heliyon
|
May 2, 2024
Unconventional strategy could be the future: From target to KRAS broad range treatment
Sara Fancelli, Giulia Petroni, Serena Pillozzi, et al.
Page
of 24